Popular search terms:
Search Results Label
57 results found-
Seqirus | Influenza Expertise
Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.
https://www.seqirus.com/expertise -
Seqirus | Meet Our Leadership
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
https://www.seqirus.com/our-company/leadership -
Seqirus | Global Manufacturing Network
Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.
https://www.seqirus.com/...ring/global-manufacturing-network -
Sitemap
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
https://www.seqirus.com/sitemap -
Gordon Naylor
Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.
https://www.seqirus.com/our-company/leadership/gordon-naylor -
Seqirus | Vaccine Technologies
Seqirus employs both egg and cell-based manufacturing systems to ensure the availability of our influenza vaccines. Learn more about our optimised technology.
https://www.seqirus.com/manufacturing/technologies -
Microsoft Word - Seqirus Methodological Statement for EFPIA
2015 from the combined strength and expertise of bioCSL Inc. and the influenza and control of influenza globally, with extensive research and production expertise.
https://www.seqirus.com/-/media/seqirus/pdfs/seqirus-methodological-statement-for-abpi--updated-14-march-20170.pdf -
Seqirus Methodological Statement for EFPIA
2015 from the combined strength and expertise of bioCSL Inc. and the influenza and control of influenza globally, with extensive research and production expertise.
https://www.seqirus.com/-/media/seqirus/pdfs/seqirus-methodological-statement-for-efpia-2015.pdf -
Seqirus Methodological Statement for EFPIA CY2017
2015 from the combined strength and expertise of bioCSL Inc. and the influenza and control of influenza globally, with extensive research and production expertise.
https://www.seqirus.com/-/media/seqirus/pdfs/seqirus-methodological-statement-for-efpia-cy2017.pdf -
Microsoft Word - Seqirus Methodological Statement for EFPIA CY2018
2015 from the combined strength and expertise of bioCSL Inc. and the influenza and control of influenza globally, with extensive research and production expertise.
https://www.seqirus.com/-/media/seqirus/pdfs/seqirus-methodological-statement-for-efpia-cy2018.pdf